These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 20413857)

  • 1. S-adenosylhomocysteine: a better marker of the development of Alzheimer's disease than homocysteine?
    Chang PY; Lu SC; Chen CH
    J Alzheimers Dis; 2010; 21(1):65-6. PubMed ID: 20413857
    [No Abstract]   [Full Text] [Related]  

  • 2. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2007 Dec; 28(12):1834-9. PubMed ID: 16996649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease.
    Panza F; Capurso C; D'Introno A; Colacicco AM; Capurso A; Solfrizzi V
    Neurobiol Aging; 2008 Mar; 29(3):478-80. PubMed ID: 17125887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease.
    Panza F; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Vendemiale G; Capurso A; Solfrizzi V
    J Alzheimers Dis; 2009; 16(3):467-70. PubMed ID: 19276539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased homocysteine and decreased adenosine formation in Alzheimer's disease.
    Selley ML
    Neurol Res; 2004 Jul; 26(5):554-7. PubMed ID: 15265273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
    Fu W; Dudman NP; Perry MA; Young K; Wang XL
    Biochem Biophys Res Commun; 2000 Apr; 271(1):47-53. PubMed ID: 10777679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine levels are not increased in murine models of Alzheimer's disease.
    Santiard-Baron D; Aupetit J; Janel N
    Neurosci Res; 2005 Dec; 53(4):447-9. PubMed ID: 16213620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homocysteine and dementia].
    Kessler H; Bleich S; Falkai P; Supprian T
    Fortschr Neurol Psychiatr; 2003 Mar; 71(3):150-6. PubMed ID: 12624852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of S-adenosylmethionine-homocysteine methyltransferase activity in hepatoma cells.
    Kuchino Y; Yasuda T; Nishimura S
    Cancer Res; 1977 Jan; 37(1):206-8. PubMed ID: 187333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonyl proteins as a clinical marker in Alzheimer's disease and its relation to tryptophan degradation and immune activation.
    Greilberger J; Fuchs D; Leblhuber F; Greilberger M; Wintersteiger R; Tafeit E
    Clin Lab; 2010; 56(9-10):441-8. PubMed ID: 21086789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and Alzheimer's disease: a modifiable risk?
    Dwyer BE; Raina AK; Perry G; Smith MA
    Free Radic Biol Med; 2004 Jun; 36(11):1471-5. PubMed ID: 15135184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of S-adenosylhomocysteine in the biological utilization of S-adenosylmethionine.
    Cantoni GL
    Prog Clin Biol Res; 1985; 198():47-65. PubMed ID: 4070312
    [No Abstract]   [Full Text] [Related]  

  • 14. S-adenosylhomocysteine, but not homocysteine, is toxic to yeast lacking cystathionine beta-synthase.
    Christopher SA; Melnyk S; James SJ; Kruger WD
    Mol Genet Metab; 2002 Apr; 75(4):335-43. PubMed ID: 12051965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine: a new risk factor for Alzheimer's disease?
    Mizrahi EH; Jacobsen DW; Friedland RP
    Isr Med Assoc J; 2002 Mar; 4(3):187-90. PubMed ID: 11908260
    [No Abstract]   [Full Text] [Related]  

  • 16. The methionine-homocysteine cycle and its effects on cognitive diseases.
    Miller AL
    Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects on growth, homocysteine, and related compounds of two inhibitors of S-adenosylhomocysteine catabolism, 3-deazaadenosine, and 3-deazaaristeromycin, in C3H/10T1/2 cells.
    Djurhuus R; Svardal AM; Ueland PM
    Cancer Res; 1989 Jan; 49(2):324-30. PubMed ID: 2910451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.
    Svardal AM; Djurhuus R; Refsum H; Ueland PM
    Cancer Res; 1986 Oct; 46(10):5095-100. PubMed ID: 3756867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanism of action of S-methylmethionine].
    Areshkina LIa; Skorobogatova EP; Bukin VN
    Prikl Biokhim Mikrobiol; 1979; 15(1):12-7. PubMed ID: 95822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of S-adenosylhomocysteine with isolated rat hepatocytes.
    Aarbakke J; Ueland PM
    Mol Pharmacol; 1981 May; 19(3):463-9. PubMed ID: 7266470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.